Poor Reliability between Cochrane Reviewers and Blinded External Reviewers When Applying the Cochrane Risk of Bias Tool in Physical Therapy Trials-Reference-Cited by-同舟云学术

Poor Reliability between Cochrane Reviewers and Blinded External Reviewers When Applying the Cochrane Risk of Bias Tool in Physical Therapy Trials

Published:2014-05-13 Issue:5 Volume:9 Page:e96920
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Armijo-Olivo Susan,Ospina Maria,da Costa Bruno R.,Egger Matthias,Saltaji Humam,Fuentes Jorge,Ha Christine,Cummings Greta G.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference54 articles.

1. Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review;S Armijo-Olivo;Physical Therapy,2008

2. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists;D Moher;Controlled Clinical Trials,1995

3. Higgins J, Altman DG (2008) Chapter 8: Assessing risk of bias in included studies. In: Higgins J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 500 [updated February 2008] version 5.0 ed: Available from www.cochrane-handbook.org, February, 2008.

4. Lundh A, Gotzsche PC (2008) Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Medical Research Methodology 8.

5. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials;KF Schulz;Journal of the American Medical Association,1995

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guidance on how to efficiently find, choose, and use available systematic reviews was developed;Journal of Clinical Epidemiology;2024-09

2. Systematic review of added immunotherapy in traditional treatment for HER2 positive breast cancer patients;Innovative Practice in Breast Health;2024-09

3. Zero‐ and few‐shot prompting of generative large language models provides weak assessment of risk of bias in clinical trials;Research Synthesis Methods;2024-08-23

4. Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews;Trials;2024-06-21

5. The Benefits and Risks of Receiving Investigational Solid Tumor Drugs in Randomized Trials;Annals of Internal Medicine;2024-06